Epidemic Landscape and Forecasting of SARS-CoV-2 in India

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

India was one of the countries to institute strict measures for SARS-CoV-2 control in early phase. Since, then, the epidemic growth trajectory was slow before registering an explosion of cases due to local cluster transmissions.

METHODS

We estimated growth rate and doubling time of SARS-CoV-2 for India and high burden states using crowd sourced time series data. Further, we also estimated Basic Reproductive Number (R0) and time dependent reproductive number (Rt) using serial intervals from the data. We compared the R0 estimated from five different methods and R0 from SB was further used in analysis. We modified standard SIR models to SIRD model to accommodate deaths using R0 with the Sequential Bayesian method (SBM) for simulation in SIRD models.

RESULTS

On an average, 2.8 individuals were infected by an index case. The mean serial interval was 3.9 days. The R0 estimated from different methods ranged from 1.43 to 1.85. The mean time to recovery was 14 ± 5.3 days. Daily epidemic growth rate of India was 0.16 [95%CI; 0.14, 0.17] with a doubling time of 4.30 days [95%CI; 3.96, 4.70]. From the SIRD model, it can be deduced that the peak of SARS-CoV-2 in India will be around mid-July to early August 2020 with around 12.5% of population likely to be infected at the peak time.

CONCLUSIONS

The pattern of spread of SARS-CoV-2 in India is suggestive of community transmission. There is a need to increase fund for infectious disease research and epidemiologic studies. All the current gains may be reversed rapidly if air travel and social mixing resumes rapidly. For the time being, these must be resumed only in a phased manner, and should be back to normal levels only after we are prepared to deal with the disease with efficient tools like vaccine or a medicine.

Article activity feed

  1. SciScore for 10.1101/2020.04.14.20065151: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    12 Package ggplot2 was mainly used to create figures along with features from base R.
    ggplot2
    suggested: (ggplot2, RRID:SCR_014601)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Our analysis has certain limitations. Firstly, there may be underreporting of cases and lack of validated data for research purposes available to the public.However, we compared the incidence from our dataset to the aggregated numbers elsewhere like European Disease Prevention and Control 23and Worldometer5 and the figures were similar. Another issue in estimating the parameters is the presence of super spreaders and asymptomatic cases. The estimated proportion of asymptomatic cases can be as high as 10% in the population.27 The virus can be spread around during asymptomatic stage and delays from onset to reporting or treatment can be as high as 11 days.28 Nonetheless, pooling estimates across several studies will aid in computing values that are closer to the true estimates. In conclusion, our study provides information on India specific estimates of SARS-CoV-2 transmission parameters using real world data for the first time and shows that measures taken till date have been effective in reducing the spread of disease. However, the rising incidence and pattern of spread is suggestive of community transmission and is likely to increase cases in the future. The availability of individual level data is critical to assess the effectiveness of ongoing measures and plan future strategies. There is a need to increasingly fund infectious disease research and epidemiologic studies and make that data available in the public domain. Future studies could focus on studying genetic variati...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.